PROTACs: great opportunities for academia and industry (an update from 2020 to 2021)Ming He, Yu Rao, Yuna He et al.|Signal Transduction and Targeted Therapy|2022Cited by 251
Synthesis of selective PAK4 inhibitors for lung metastasis of lung cancer and melanoma cellsPeilu Song, Maosheng Cheng, Fan Zhao et al.|Acta Pharmaceutica Sinica B|2022Cited by 27
The application of PROTACs in immune-inflammation diseasesChao Zhang, Yu Rao, Xiuyun Sun et al.|Bioorganic & Medicinal Chemistry|2024Cited by 10
Developing potent anti-inflammatory IRAK4-targeting PROTACs with simplified CRBN ligandsYu Rao, Xin Zhai, Peilu Song et al.|Chinese Chemical Letters|2025Cited by 2